These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37319429)

  • 1. Comparative assessment of homemade ELISA and lateral flow assay (LFA)in the rapid, specific and sensitive detection of SARS-CoV-2 anti-nucleocapsid protein in sera of Egyptian patients.
    El-Shershaby A; Hussein N; Ali E; El-Hakim A; Tabll A; Shaheen M; Ali I; Elshall M; Shahein Y
    J Immunoassay Immunochem; 2023 Jul; 44(4):338-359. PubMed ID: 37319429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.
    Sil BK; Jamiruddin MR; Haq MA; Khondoker MU; Jahan N; Khandker SS; Ali T; Oishee MJ; Kaitsuka T; Mie M; Tomizawa K; Kobatake E; Haque M; Adnan N
    Int J Nanomedicine; 2021; 16():4739-4753. PubMed ID: 34267520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.
    Salem R; Elshamy AM; Kamel N; Younes S; Marie OM; Waly FR; El-Kholy AA; Elmenofy W
    Biotechnol Lett; 2022 Dec; 44(12):1507-1517. PubMed ID: 36319880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a recombinant nucleocapsid protein-based ELISA for the detection of IgM and IgG antibodies to SARS-CoV-2.
    Ranjbar M; Asadi M; Nourigorji M; Sarkari B; Mostafavi-Pour Z; Zomorodian K; Shabaninejad Z; Taheri-Anganeh M; Maleksabet A; Moghadami M; Savardashtaki A
    Biotechnol Appl Biochem; 2022 Dec; 69(6):2592-2598. PubMed ID: 34965611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay.
    Ahmadi A; Mirzaeizadeh Z; Omidfar K
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):210-218. PubMed ID: 34678096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices.
    McGrath J; O'Doherty L; Conlon N; Dunne J; Brady G; Ibrahim A; McCormack W; Walsh C; Domegan L; Walsh S; Kenny C; Allen N; Fleming C; Bergin C
    Front Public Health; 2023; 11():1245464. PubMed ID: 37841735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of specific human antibodies against SARS-CoV-2 receptor binding domain by rapid in-house ELISA.
    Hussein NA; Ali EAA; El-Hakim AE; Tabll AA; El-Shershaby A; Salamony A; Shaheen MNF; Ali I; Elshall M; Shahein YE
    Hum Antibodies; 2022; 30(2):105-115. PubMed ID: 35431235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study.
    Peghin M; Bontempo G; De Martino M; Palese A; Gerussi V; Graziano E; Fabris M; D'Aurizio F; Sbrana F; Ripoli A; Curcio F; Isola M; Tascini C
    BMC Infect Dis; 2022 Oct; 22(1):810. PubMed ID: 36316641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera.
    Deschermeier C; Ehmen C; von Possel R; Murawski C; Rushton B; Amuasi J; Sarpong N; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Oestereich L; Duraffour S; Pahlmann M; Emmerich P
    J Clin Microbiol; 2022 Jun; 60(6):e0007522. PubMed ID: 35574677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance estimation of two in-house ELISA assays for COVID-19 surveillance through the combined detection of anti-SARS-CoV-2 IgA, IgM, and IgG immunoglobulin isotypes.
    Ramírez-Reveco A; Velásquez G; Aros C; Navarrete G; Villarroel-Espíndola F; Navarrete M; Fica A; Plaza A; Castro N; Verdugo C; Acosta-Jamett G; Verdugo CC
    PLoS One; 2023; 18(2):e0270388. PubMed ID: 36745590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Detection of SARS-CoV-2 Seroconversion in Humans with Aggregation-Induced Near-Infrared Emission Nanoparticle-Labeled Lateral Flow Immunoassay.
    Chen R; Ren C; Liu M; Ge X; Qu M; Zhou X; Liang M; Liu Y; Li F
    ACS Nano; 2021 May; 15(5):8996-9004. PubMed ID: 33928784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
    Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort.
    Bahgat MM; Nasraa MH; Nadeem R; Amer K; Hassan WA; ELGarhy FM; Reda S; Fasemore AM; Förstner KU; Abd-Elshafy DN
    Curr Microbiol; 2023 Nov; 81(1):24. PubMed ID: 38032503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel highly specific biotinylated MAC-ELISA for detection of anti-SARS-CoV-2 nucleocapsid antigen IgM antibodies during the acute phase of COVID-19.
    Lopes-Luz L; Fogaça MBT; Bentivoglio-Silva BG; Saavedra DP; Alves LM; Franca LV; Crispim GJB; de Andrade IA; Ribeiro BM; Nagata T; Bührer-Sékula S
    Braz J Microbiol; 2023 Dec; 54(4):2893-2901. PubMed ID: 37930615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.